Advancing Clinical and Translational Science.

Abstract

The vision for the 2015–2020 American Society for Clinical Pharmacology and Therapeutics (ASCPT) strategic plan is that ASCPT's influence and leadership make it the authority on the science and practice of translational medicine, building on a foundation of clinical pharmacology and therapeutics [http://www.ascpt.org/About-ASCPT/ASCPT-Strategic-Plan]. The vision for Clinical and Translational Science (CTS) is well-suited for ASCPT.(1) Our vision is to become the beacon and organizing principle for the field of translational medicine, as well as to provide a vehicle for ASCPT member publications. The ASCPT definition of translational medicine(1) serves as a framework for the CTS strategy. In brief, “From ASCPT's perspective, translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. For clinical pharmacology, the focus of translational research is on the discovery, development, regulation and use of pharmacologic agents to improve clinical outcome, and inform optimal use of therapeutics in patients.” This article is protected by copyright. All rights reserved